Hypothalamo-pituitary insufficiency associated with ectrodactyly-ectodermal dysplasia-clefting syndrome

Nihal Hatipoğlu1, Selim Kurtoğlu, Derya Büyükayhan

  • 1Department of Pediatric Endocrinology, Sisli Etfal Education and Research Hospital, İstanbul, Turkey. nihalhatipoglu@yahoo.com

Insights

Ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome, a rare genetic disorder, can cause hormonal deficiencies. This study highlights two cases of EEC syndrome with hypothalamo-pituitary insufficiency, emphasizing the need for endocrine evaluation.

Area of Science:

  • Genetics
  • Endocrinology
  • Developmental Biology

Background:

  • Ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome is a rare autosomal dominant disorder.
  • It presents with ectrodactyly, ectodermal dysplasia, and facial clefting, often with other congenital anomalies.
  • While midline defects suggest potential hypothalamo-pituitary endocrinopathy, hormonal disorders are infrequently reported in EEC syndrome.

Observation:

  • This report details two pediatric patients diagnosed with EEC syndrome.
  • Both patients exhibited symptoms consistent with EEC syndrome and were found to have hypothalamo-pituitary insufficiency.
  • The clinical presentation underscores the variability and potential endocrine involvement in EEC syndrome.

Findings:

  • The study identifies hypothalamo-pituitary insufficiency as a significant, though rarely reported, complication in EEC syndrome.
  • Hormonal disorders, specifically insufficiency, were confirmed in the presented cases of EEC syndrome.
  • This highlights a crucial aspect of the syndrome's complex phenotype.

Implications:

  • Early endocrine screening and monitoring are crucial for patients with EEC syndrome.
  • Recognizing hypothalamo-pituitary insufficiency can lead to timely diagnosis and management, improving patient outcomes.
  • This emphasizes the importance of a multidisciplinary approach in managing rare genetic syndromes like EEC.

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Renal Tubule and Collecting Duct01:24

Renal Tubule and Collecting Duct

The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...